Media 3rd June 2025
Business Update – DaaP Buyer Announcement
3rd June 2025 Whilst the Company had anticipated that the formal DaaP buyer announcement would be made imminently, we reiterate that this remains subject to the buyer’s internal processes and the broader scheduling considerations related to other listed securities within their ecosystem. As previously communicated, the Company has fulfilled all… Read more
Media 2nd May 2025
Business Update – DaaP Buyer Announcement
2nd May 2025 The Company acknowledges the continued anticipation, anxiety and frustration surrounding the formal DaaP buyer announcement. We wish to reassure shareholders that the Company have fulfilled all of its obligations in this process and have disclosed as much information about the DaaP buyer as is legally permissible under… Read more
Media 28th April 2025
Pre-announcement Business Update
28th April 2025 The DaaP buyer is one of the world’s largest and most respected healthcare companies. Founded in the United States, it operates globally across three major sectors: pharmaceuticals, medical, and consumer health, and has proudly increased its dividend every year for the past 63 years. Their formal announcement… Read more